← All trials
NCT04368819
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2020
- Primary completion
- Jul 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Apr 30, 2020
- Last posted
- May 7, 2020
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of BrazilLead sponsor
- University of Sao PauloOverall official - principal investigator
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
- University of Sao PauloReponsible party - principal investigator
- University of Sao PauloCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.